Chemistry:Indium (111In) altumomab pentetate
From HandWiki
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Mouse |
Target | CEA |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
(what is this?) (verify) |
Indium (111In) altumomab pentetate (INN) (USP, indium In 111 altumomab pentetate; trade name Hybri-ceaker) is a mouse monoclonal antibody linked to pentetate which acts as a chelating agent for the radioisotope indium-111. The drug is used for the diagnosis of colorectal cancer[1][2] but has not been approved for use.[3]
References
- ↑ "lnternational Nonproprietary Names for Pharmaceutical Substances". WHO Drug Information 7 (3). 1993. http://whqlibdoc.who.int/inn/INN_1993_list33.pdf. Retrieved 2009-09-22.
- ↑ "Cumulartive [sic Designated Products List"]. U.S. Food and Drug Administration. https://www.scribd.com/doc/1440358/US-Food-and-Drug-Administration-list.
- ↑ "Radioimmunodetection of Cancer". Targeted Molecular Imaging in Oncology. New York, NY: Springer. 2001. pp. 88-101 (92). ISBN 9780387950280. https://books.google.com/books?id=7QQnKPPxrZ0C&dq=Indium+%28111In%29+altumomab+pentetate&pg=PA93.
Original source: https://en.wikipedia.org/wiki/Indium (111In) altumomab pentetate.
Read more |